Taiwan and NICE Renew Partnership Agreement to Deepen Taiwan–UK Healthcare Policy Collaboration

To further strengthen Taiwan’s evidence-based healthcare decision-making framework, under the witness of the Ministry of Health and Welfare (MOHW), Taiwan’s National Health Insurance Administration (NHIA) and the Center for Drug Evaluation (CDE) renewed their partnership agreement with the UK National Institute for Health and Care Excellence (NICE) on May 11, 2026. The renewed agreement marks the beginning of a new phase of Taiwan–UK collaboration on Health Technology Assessment (HTA), aligned with Taiwan’s ongoing legislative efforts to establish the Center for Health Technology Assessment as an administrative corporation. The collaboration will focus on advancing innovative healthcare assessment frameworks, healthcare digital transformation, HTA talent development, and the incorporation of societal perspectives into healthcare decision-making. NICE is widely recognised as one of the leading global HTA organisations, renowned for its rigorous, evidence-based and transparent approach to health technology assessment, and its work at the forefront of HTA methodology globally. Following the signing of the initial partnership agreement in May 2023, during Minister Chung-Liang Shih’s...